SUDARSHAN PHARMA INDUSTRIES
Back to Cashflow Statement
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹35 Cr | ₹7.75 Cr | ₹-29 Cr | ₹-3.82 Cr | ₹2.77 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹35 Cr |
| Mar2024 | ₹7.75 Cr |
| Mar2023 | ₹-29 Cr |
| Mar2022 | ₹-3.82 Cr |
| Mar2021 | ₹2.77 Cr |
How is Cash Flow from Operating Activities of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹35 Cr | 354.24 | |
| Mar2024 | ₹7.75 Cr | Positive | |
| Mar2023 | ₹-29 Cr | Negative | |
| Mar2022 | ₹-3.82 Cr | Negative | |
| Mar2021 | ₹2.77 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹977.0 Cr | 5.7% | -4.5% | 23.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 5.7% |
-4.5% |
23.7% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses